Is the platelet-raising medicine that costs 6,000 yuan per box roplastin/romigrastim?

Romiplostim/Romiplostim is a recombinant protein used to treat thrombocytopenia, especially for patients with chronic immune thrombocytopenia (ITP). The drug promotes platelet production in the bone marrow by activating the thrombopoietin receptor, thereby effectively increasing the patient's platelet count and reducing the risk of bleeding. The use of roplastin provides a new treatment option for many patients with thrombocytopenia, and its efficacy has been widely recognized clinically.

At present, the original drug of Roprostim has been launched in the Chinese market and is included in the scope of medical insurance, which provides certain financial support to patients. However, due to its relatively short time on the market, patients may face certain difficulties when purchasing it. In China, the price of the original research version of Lopilastin is about more than 9,000 RMB per tube, while the price of the Hong Kong version is slightly lower, about more than 8,000 RMB. These prices may change due to exchange rate fluctuations, and patients should pay attention to the actual prices when purchasing medicines.

In addition to the domestic market, the original drug of Ropremilast is also available in overseas markets, such as the European version and the German version, each of which costs about 10,000 yuan. Although the prices of these different versions of the drug vary, their ingredients are basically the same and their efficacy should be similar. It should be pointed out that with the development of the international drug market, there are currently no generic drugs of Ropremilast on the market, which makes patients relatively limited in choosing drugs.

During the use of roplastin, patients need to undergo regular blood monitoring to evaluate changes in platelet levels and possible side effects. Although this drug works well at raising platelet levels, it may have some side effects, such as headaches, joint pain, or other allergic reactions. Therefore, patients should maintain close communication with their doctors during use and promptly report their physical conditions so that doctors can adjust the medication plan according to the actual situation.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim